MedPath

HIGH ALTITUDE CARDIOVASCULAR RESEARCH IN THE ANDES

Not Applicable
Registration Number
PER-011-12
Lead Sponsor
INSTITUTO AUXOLOGICO ITALIANO,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) LOWLANDERS STUDY
- MALE AND FEMALE SUBJECTS AGED 18-65 YEARS
- PERMANENT RESIDENT AT LOW (<500 M) ALTITUDE
- CONVENTIONAL SYSTOLIC BP (AVERAGE OF 2 MEASUREMENTS) 140-159 MMHG OR CONVENTIONAL DIASTOLIC BP 90-99 MMHG IN SUBJECTS UNTREATED OR AFTER 4 WEEKS OF WASHOUT
- MEAN DAYTIME SYSTOLIC BP ≥135 AND <150 MMHG AND/OR MEAN DAYTIME DIASTOLIC BP ≥85 AND <95 MMHG IN SUBJECTS UNTREATED OR AFTER 4 WEEKS OF WASHOUT
- WRITTEN INFORMED CONSENT TO PARTICIPATE IN THE STUDY.
2) HIGHLANDERS STUDY:
- MALE AN FEMALE SUBJECTS AGED 18-65 YEARS WITHOUT CARE OF THEIR BLOOD PRESSURE STATUS
- WRITTEN INFORMED CONSENT TO PARTICIPATE IN THE STUDY
- PERMANENT RESIDENCE AT ALTITUDE ABOVE 4000 M.

Exclusion Criteria

1) LOWLANDERS STUDY
- CONVENTIONAL SYSTOLIC BP (AVERAGE OF 2 MEASUREMENTS) ≥150 MMHG AND CONVENTIONAL DIASTOLIC BP ≥95 MMHG IN TREATED SUBJECTS
- REGULAR USE OF 2 OR MORE ANTIHYPERTENSIVE DRUGS (WITH THE EXCEPTION OF SUBJECTS ON 2 ANTYHYPERTENSIVE DRUGS IN LOW DOSES)
- TREATED ANTIHYPERTENSIVE SUBJECTS IN WHOM WITHDRAWAL OF TREATMENT IS DEEMED UNETHICAL BY THE INVESTIGATOR (EG BECAUSE OF THE EXISTENCE OF COMPELLING INDICATIONS OTHER THAN HYPERTENSION FOR CONTINUOUS USE OF PEVIOUSLY USED ANTIHYPERTENSIVE AGENT)
- CONTRAINDICATIONS (INCLUDING A HISTORY OF ADVERSE REACTIONS) TO ANGIOTENSIN RECEPTOR BLOCKERS OR CALCIUM ANTAGONISTS.
- HISTORY OF SERIOUS MOUNTAIN SICKNESS
- SUBJECTS WHO OVER 3 MONTHS PRECEDING INCLUSION IN THE STUDY SPENT CONSIDERABLE (>1 WEEK) AMOUNT OF TIME AT ALTITUDES ABOVE 2500 M.
- CARDIOVASCULAR DISEASES OTHER THAN HYPERTENSION (CORONARY HEART DISEASE, HEART FAILURE, ATRIAL FIBRILLATION, VALVULAR OR CONGENITAL HEART DISEASE, CARDIOMYOPATHIES, CEREBROVASCULAR DISEASE, PERIPHERAL ARTERY DISEASE, AORTIC ANEURYSM)
- SUSPECTED OR CONFIRMED SECONDARY HYPERTENSION
- DIABETES MELLITUS
- SERIOUS RESPIRATORY DISORDERS
- OTHER CONDITIONS DEEMED RELEVANT BY THE INVESTIGATOR (INCLUDING LIVER DISEASE, RENAL DISEASE, THYROID DISORDERS)
- BMI ≥35 KG/M2
- UPPER ARM CIRCUMFERENCE >32 CM
- KNOWN SEVERE OBSTRUCTIVE SLEEP APNEA (APNEA-HYPOPNEA INDEX >30 OR USE OF CPAP) OR EXCESSIVE DAYTIME SLEEPINESS (EPWORTH SLEEPINESS SCALE >10)
- PREGNANCY
- PREMENOPAUSAL WO

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath